SCHEMBL4923939

SCHEMBL4923939

CC1(C)CC(=O)c2c(S(C)(=O)=O)sc(C(=O)OCCc3cccc(C(F)(F)F)c3)c2C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
PKM P14618 2/20 0.46
MAPT P10636 3/20 0.39
HPGD P15428 1/20 0.39
ALOX5 P09917 1/20 0.39
LRRK2 Q5S007 1/20 0.38
LMNA P02545 2/20 0.37
TP53 P04637 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.36
PRKCA P17252 1/20 0.36
PRKCD Q05655 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP3A4 P08684 3/20 0.35
USP2 O75604 2/20 0.35
CYP1A2 P05177 2/20 0.35
NR1I2 O75469 1/20 0.35
ADRB1 P08588 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4927718 0.91 ALDH1A1 (0.47) ALDH1A1PKMMAPTHPGDLRRK2
SCHEMBL4930275 0.81 ALDH1A1 (0.50) ALDH1A1PKMMAPTHPGDLRRK2
SCHEMBL4929581 0.80 ALDH1A1 (0.46) ALDH1A1PKMMAPTLRRK2LMNA
SCHEMBL4937751 0.78 ALDH1A1 (0.49) ALDH1A1PKMMAPTLRRK2LMNA
SCHEMBL4929155 0.78 ALDH1A1 (0.52) ALDH1A1PKMMAPTHPGDLRRK2
SCHEMBL4929847 0.77 ALDH1A1 (0.48) ALDH1A1PKMMAPTLRRK2LMNA
SCHEMBL7433903 0.76 ALDH1A1 (0.73) ALDH1A1PKMMAPTLRRK2LMNA
SCHEMBL4918258 0.76 ALDH1A1 (0.47) ALDH1A1PKMMAPTLRRK2LMNA
SCHEMBL4925499 0.74 ALDH1A1 (0.47) ALDH1A1PKMMAPTLRRK2LMNA
SCHEMBL4929382 0.73 ALDH1A1 (0.50) ALDH1A1PKMMAPTLRRK2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
EP-1765814-A1 CONDENSED THIOPHENE DERIVATIVES AND THEIR USE AS CYCLIC GLP-1 AGONISTS NOVO NORDISK A/S (DK) 2007-03-28 EP disclosed
WO-2006003096-A1 CONDENSED THIOPHENE DERIVATIVES AND THEIR USE AS CYCLIC GLP-1 AGONISTS NOVO NORDISK A/S (DK) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists GLP1R, GIPR, GCGR ALDH1A1 2002/4885PKM 2177/4885MAPT 4242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.